122 related articles for article (PubMed ID: 21718818)
1. Surgical resection of locally advanced pulmonary adenocarcinoma after gefitinib therapy.
Liu M; Jiang G; He W; Zhang P; Song N
Ann Thorac Surg; 2011 Jul; 92(1):e11-2. PubMed ID: 21718818
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-myoepithelial carcinoma of the lung.
Sainathan S; Pugalenthi A; Danovich S; Arif F; Andaz S
Am Surg; 2012 May; 78(5):E290-1. PubMed ID: 22691334
[No Abstract] [Full Text] [Related]
3. Surgical resection of lung adenocarcinoma without EGFR mutation after neoadjuvant gefitinib treatment.
Shen H; Zhong X; Ge XQ; Huang JJ; Yuan Y
Clin Respir J; 2010 Jul; 4(3):192-3. PubMed ID: 20565499
[No Abstract] [Full Text] [Related]
4. How should synchronous multiple primary adenocarcinomas of the lung be resected?
Yasuda M; Nagashima A; Haro A; Saitoh G
Ann Thorac Surg; 2014 May; 97(5):e151-3. PubMed ID: 24792307
[TBL] [Abstract][Full Text] [Related]
5. The role of gefitinib treatment for Korean never-smokers with advanced or metastatic adenocarcinoma of the lung: a prospective study.
Lee DH; Han JY; Yu SY; Kim HY; Nam BH; Hong EK; Kim HT; Lee JS
J Thorac Oncol; 2006 Nov; 1(9):965-71. PubMed ID: 17409980
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection of locally advanced epidermal growth factor receptor (EGFR) mutated lung adenocarcinoma after gefitinib and review of the literature.
Marech I; Vacca A; Gnoni A; Silvestris N; Lorusso V
Tumori; 2013; 99(5):e241-4. PubMed ID: 24362878
[TBL] [Abstract][Full Text] [Related]
7. Visualization of bronchoalveolar fistula as the presenting sign of lung cancer.
Givigliano F; La Rocca A; Salati M; Busiello L; La Manna C; Scognamiglio F; Rocco G
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):704-5. PubMed ID: 18329504
[No Abstract] [Full Text] [Related]
8. Epidermal growth factor receptor targeted therapy with gefitinib in locally advanced and metastatic primary lung adenocarcinoma.
Liam CK; Pang YK; Leow CH
Respirology; 2006 May; 11(3):287-91. PubMed ID: 16635086
[TBL] [Abstract][Full Text] [Related]
9. Resection of a pleomorphic carcinoma of the lung invading the descending aorta.
Sato Y; Saito N; Endo S; Konishi H; Kamisawa O; Otani S; Hasegawa T; Sohara Y
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1829-30. PubMed ID: 15173751
[No Abstract] [Full Text] [Related]
10. Rapid symptomatic improvement in gefitinib-treated patients with EGFR-mutated lung cancer: possible role of downregulation of inflammatory molecules?
Suspitsin EN; Levchenko EV; Moiseyenko FV; Ivantsov AO; Radzhabova SA; Matsko DE; Moiseyenko VM; Imyanitov EN
Onkologie; 2011; 34(10):559-60. PubMed ID: 21985857
[No Abstract] [Full Text] [Related]
11. Surgical resection of adenocarcinoma arising from an accessory cardiac bronchus.
Cho JH; Lee SH; Kim KT; Lee EJ
Ann Thorac Surg; 2012 Sep; 94(3):1006-8. PubMed ID: 22579897
[TBL] [Abstract][Full Text] [Related]
12. Gefitinib as first-line treatment in elderly epidermal growth factor receptor-mutated patients with advanced lung adenocarcinoma: results of a Nagano Lung Cancer Research Group study.
Asami K; Koizumi T; Hirai K; Ameshima S; Tsukadaira A; Morozumi N; Morikawa A; Atagi S; Kawahara M
Clin Lung Cancer; 2011 Nov; 12(6):387-92. PubMed ID: 21729650
[TBL] [Abstract][Full Text] [Related]
13. An unusual successfully treated case of pulmonary yolk sac tumor.
Chen CH; Chen TC; Huang WC; Chen TY; Liu HC
Ann Thorac Surg; 2008 Feb; 85(2):656-8. PubMed ID: 18222293
[TBL] [Abstract][Full Text] [Related]
14. Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations.
Morita S; Okamoto I; Kobayashi K; Yamazaki K; Asahina H; Inoue A; Hagiwara K; Sunaga N; Yanagitani N; Hida T; Yoshida K; Hirashima T; Yasumoto K; Sugio K; Mitsudomi T; Fukuoka M; Nukiwa T
Clin Cancer Res; 2009 Jul; 15(13):4493-8. PubMed ID: 19531624
[TBL] [Abstract][Full Text] [Related]
15. Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experience.
Kommareddy A; Coplin MA; Gao F; Behnken D; Romvari E; Read W; Govindan R
Lung Cancer; 2004 Aug; 45(2):221-5. PubMed ID: 15246194
[TBL] [Abstract][Full Text] [Related]
16. Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC.
Cappuzzo F; Gregorc V; Rossi E; Cancellieri A; Magrini E; Paties CT; Ceresoli G; Lombardo L; Bartolini S; Calandri C; de Rosa M; Villa E; Crino L
J Clin Oncol; 2003 Jul; 21(14):2658-63. PubMed ID: 12860941
[TBL] [Abstract][Full Text] [Related]
17. First- or second-line gefitinib therapy in unknown epidermal growth factor receptor mutants of non-small-cell lung cancer patients treated in Taiwan.
Lie CH; Chang HC; Chao TY; Chung YH; Wang JL; Wang CC; Lin MC
Clin Lung Cancer; 2011 Mar; 12(2):116-24. PubMed ID: 21550558
[TBL] [Abstract][Full Text] [Related]
18. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet.
Fischer S; Darling G; Pierre AF; Sun A; Leighl N; Waddell TK; Keshavjee S; de Perrot M
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1129-34. PubMed ID: 18407511
[TBL] [Abstract][Full Text] [Related]
19. Dramatic response induced by vemurafenib in a BRAF V600E-mutated lung adenocarcinoma.
Peters S; Michielin O; Zimmermann S
J Clin Oncol; 2013 Jul; 31(20):e341-4. PubMed ID: 23733758
[No Abstract] [Full Text] [Related]
20. Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation.
Ko JH; Shih YC; Hui RC; Yang CH
J Clin Oncol; 2011 Mar; 29(7):e169-70. PubMed ID: 21149656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
